# A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer

> **NCT06145399** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Breast Cancer
- Breast Carcinoma
- Metastatic Breast Cancer
- Metastatic Breast Carcinoma
- Female Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** 18F-FDG PET/CT
- **DIAGNOSTIC_TEST:** [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone PET Imaging
- **DRUG:** 18F-FDHT

## Key facts

- **NCT ID:** NCT06145399
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-10-24
- **Primary completion:** 2024-04-29
- **Final completion:** 2024-04-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No accruals
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06145399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06145399, "A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06145399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*